MyFinsight
Home
Blog
About
Back
Cash Flow
Tempest Therapeutics, Inc. (TPST)
Tempest Therapeutics, Inc. (TPST)
source: myfinsight.com
Proceeds from issuance of
common stock,...
$1,753K
Cash provided by
financing activities
$1,753K
(265.97%↑ Y/Y)
Net decrease in
cash, cash...
-$1,026K
(93.58%↑ Y/Y)
Canceled cashflow
$1,753K
Research and development
expense funded by...
$1,710K
Accounts payable
$1,411K
(-37.73%↓ Y/Y)
Non-cash lease expense
$299K
(-44.53%↓ Y/Y)
Depreciation expense
$60K
(-55.56%↓ Y/Y)
Cash used in
operating activities
-$2,779K
(83.12%↑ Y/Y)
Canceled cashflow
$3,480K
Net loss
-$5,244K
(72.00%↑ Y/Y)
Accrued expenses and
other liabilities
-$335K
(89.42%↑ Y/Y)
Operating lease
liabilities
-$294K
(15.52%↑ Y/Y)
Prepaid expenses and
other assets
$269K
(179.35%↑ Y/Y)
Stock-based compensation
expense
-$117K
(-104.72%↓ Y/Y)
Back